logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Songhua Fan

hutchmed
H指数:24
被引数:4,296

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study

Tazemetostat（一种EZH2抑制剂）在中国复发性/难治性滤泡性淋巴瘤患者中的有效性和安全性：一项多中心、单臂、Ⅱ期研究

eClinicalMedicine
IF10
2025-08-180
PREAI
Junning Cao; Guangliang Chen; Lihua Qiu; Liling Zhang; Ming Jiang; Ying Cheng; Qiaohua Zhang; Lihong Liu; Ping Li; Yuerong Shuang; Huaqing Wang; Hongwei Xue; Huijing Wu; Meifang Zheng; Keshu Zhou; Zhiming Li; Hongmei Jing; Wei Yang; Zunmin Zhu; Wenyu Li; Jiaxuan Wangwu; Heyu Huang; Qiantao Jia; Dongmei Chen; Songhua Fan; M. Ming Shi; Weiguo Su
Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study

sovleplenib (HMPL-523) 在中国 (ESLIM-01) 成人慢性原发性免疫性血小板减少症患者中的疗效和安全性: 一项随机，双盲，安慰剂对照的3期研究

LANCET HAEMATOLOGY
IF17.7
2024-08-013
PRE
Hu, Yu; Liu, Xiaofan; Zhou, Hu; Wang, Shujie; Huang, Ruibin; Wang, Yi; Du, Xin; Sun, Jing; Zhou, Zeping; Yan, Zhenyu; Chen, Wenming; Wang, Wei; Liu, Qingchi; Zeng, Qingshu; Gong, Yuping; Yin, Jie; Shen, Xuliang; Ye, Baodong; Chen, Yun; Xu, Yajing; Sun, Huiping; Cheng, Yunfeng; Liu, Zhuogang; Wang, Chunling; Yuan, Guolin; Zhang, Xiaohui; Li, Xin; Cheng, Peng; Guo, Xinhong; Jiang, Zhongxing; Yang, Feng'e; Yang, Linhua; Luo, Chengwei; Xiao, Taiwu; Fu, Sisi; Yin, Hongyan; Guo, Xiaojun; Xu, Qian; Fan, Songhua; Shi, Michael M.; Su, Weiguo; Mei, Heng; Yang, Renchi
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-03-018
OAAI
Zhang, Panpan; Shi, Si; Xu, Jianming; Chen, Zhendong; Song, Lijie; Zhang, Xing; Cheng, Ying; Zhang, Yanqiao; Ye, Feng; Li, Zhiping; Yin, Fei; Ji, Dongmei; Gao, Heli; Li, Yi; Chen, Wei; Yang, Minjie; Weng, Desheng; Wu, Chunjiao; Ma, Yue; Sheng, Wang; Zhao, Yaqin; Yin, Xiaolei; Shen, Weina; Su, Weiguo; Shi, Michael; Fan, Songhua; Tan, Panfeng; Xu, Qian; Lu, Min; Shen, Lin
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study
LANCET HAEMATOLOGY
IF17.7
2023-06-016
PRE
Liu, Xiaofan; Zhou, Hu; Hu, Yu; Yin, Jie; Li, Junmin; Chen, Wenming; Huang, Ruibin; Gong, Yuping; Luo, Chengwei; Mei, Heng; Ding, Bingjie; Gu, Chengyuan; Sun, Huiping; Leng, Yun; Ji, Dexiang; Li, Yan; Yin, Hongyan; Shi, Haiyan; Chen, Keyan; Wang, Jian; Fan, Songhua; Su, Weiguo; Yang, Renchi
Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases

fruquintinib联合sintilimab治疗晚期实体瘤的1b/2期试验: 剂量扩展阶段的剂量递增和转移性结直肠癌队列

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-03-0123
PRE
Guo, Ye; Zhang, Weijie; Ying, Jieer; Zhang, Yanqiao; Pan, Yueyin; Qiu, Wensheng; Fan, Qingxia; Xu, Qi; Ma, Yue; Wang, Gang; Guo, Jing; Su, Weiguo; Fan, Songhua; Tan, Panfeng; Wang, Yan; Luo, Yang; Zhou, Hui; Li, Jin
'Health-related quality of life in patients with advanced well-differentiated pancreatic and extra pancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double- blind, phase III trials (SANET-p and SANET-ep)' (vol 169, pg 1, 2022)
EUROPEAN JOURNAL OF CANCER
IF7.1
2023-01-010
PRE
Li, Jiarui; Cheng, Yuejuan; Bai, Chunmei; Xu, Jianming; Shen, Lin; Li, Jie; Zhou, Zhiwei; Li, Zhiping; Chi, Yihebali; Yu, Xianjun; Li, Enxiao; Xu, Nong; Liu, Tianshu; Lou, Wenhui; Bai, Yuxian; Yuan, Xianglin; Wang, Xiuwen; Yuan, Ying; Chen, Jia; Guan, Sha; Fan, Songhua; Su, Weiguo
Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib

基线放射学特征可作为接受surufatinib治疗的胰腺神经内分泌肿瘤肝转移患者疗效的预测指标

CHINESE JOURNAL OF CANCER RESEARCH
IF6.3
2023-01-013
OA
Zhang, Jianwei; Zhu, Haibin; Shen, Lin; Li, Jie; Zhang, Xiaoyan; Bai, Chunmei; Zhou, Zhiwei; Yu, Xianrui; Li, Zhiping; Li, Enxiao; Yuan, Xianglin; Lou, Wenhui; Chi, Yihebali; Xu, Nong; Yin, Yongmei; Bai, Yuxian; Zhang, Tao; Xiu, Dianrong; Chen, Jia; Qin, Shukui; Wang, Xiuwen; Yang, Yujie; Shi, Haoyun; Luo, Xian; Fan, Songhua; Su, Weiguo; Lu, Ming; Xu, Jianming
Health-related quality of life in patients with advanced well-differentiated pancreatic and extrapancreatic neuroendocrine tumors treated with surufatinib versus placebo: Results from two randomized, double-blind, phase III trials (SANET-p and SANET-ep)
EUROPEAN JOURNAL OF CANCER
IF7.1
2022-07-015
PRE
Li, Jiarui; Cheng, Yuejuan; Bai, Chunmei; Xu, Jianming; Shen, Lin; Li, Jie; Zhou, Zhiwei; Li, Zhiping; Chi, Yihebali; Yu, Xianjun; Li, Enxiao; Xu, Nong; Liu, Tianshu; Lou, Wenhui; Bai, Yuxian; Yuan, Xianglin; Wang, Xiuwen; Yuan, Ying; Chen, Jia; Guan, Sha; Fan, Songhua; Su, Weiguo
Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib in FRESCO trial

FRESCO试验中接受fruquintinib治疗的转移性结直肠癌患者的质量调整生存

FUTURE ONCOLOGY
IF2.6
2021-02-106
PRE
Qin, Shukui; Li, Jin; Bai, Yuxian; Deng, Yanhong; Yang, Lei; Xu, Rui-Hua; Zhong, Haijun; Chen, Zhendong; Pan, Hongming; Guo, Weijian; Shu, Yongqian; Xu, Jianming; Peng, Cike; Chen, Yun; Li, Hongyan; Wang, Ning; Guo, Xiaojun; Peng, Mengye; Fan, Songhua; Shen, Lin
Safety Profile and Adverse Events of Special Interest for Fruquintinib in Chinese Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of the Phase 3 FRESCO Trial

中国既往接受过治疗的转移性结直肠癌患者使用Fruquintinib的安全性和不良事件: FRESCO 3期临床试验分析

ADVANCES IN THERAPY
IF4
2020-09-0817
PREAI
Li, Jin; Guo, Weijian; Bai, Yuxian; Deng, Yanhong; Yang, Lei; Chen, Zhendong; Zhong, Haijun; Xu, Ruihua; Pan, Hongming; Shu, Yongqian; Yuan, Ying; Zhou, Jianfeng; Xu, Nong; Liu, Tianshu; Ma, Dong; Wu, Changping; Cheng, Ying; Xu, Jianming; Chen, Donghui; Li, Wei; Sun, Sanyuan; Yu, Zhuang; Cao, Peiguo; Shen, Lin; Chen, Haihui; Wang, Shubin; Wang, Hongbing; Fan, Songhua; Guo, Xiaojun; Wang, Ning; Han, Rubing; Zhang, Bin; Qin, Shukui
Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer The FRESCO Randomized Clinical Trial
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
IF55
2018-06-26298
OA
Li, Jin; Qin, Shukui; Xu, Rui-Hua; Shen, Lin; Xu, Jianming; Bai, Yuxian; Yang, Lei; Deng, Yanhong; Chen, Zhen-dong; Zhong, Haijun; Pan, Hongming; Guo, Weijian; Shu, Yongqian; Yuan, Ying; Zhou, Jianfeng; Xu, Nong; Liu, Tianshu; Ma, Dong; Wu, Changping; Cheng, Ying; Chen, Donghui; Li, Wei; Sun, Sanyuan; Yu, Zhuang; Cao, Peiguo; Chen, Haihui; Wang, Jiejun; Wang, Shubin; Wang, Hongbing; Fan, Songhua; Hua, Ye; Su, Weiguo

研究方向

暂未获取到该数据
W
Weiguo Su
H 指数:23论文数:151被引数:2,592
L
Lin Shen
H 指数:62论文数:826被引数:2.6万
J
Jianming Xu
H 指数:56论文数:387被引数:2.6万
Y
Yuxian Bai
H 指数:59论文数:366被引数:1.9万
谢
谢鹏
H 指数:64论文数:447被引数:1.7万
N
Nong Xu
H 指数:30论文数:187被引数:7,557
徐
徐瑞华
H 指数:104论文数:1,466被引数:5.3万
X
Xianjun Yu
H 指数:85论文数:939被引数:3.1万
程
程颖
H 指数:84论文数:1,042被引数:4.4万
Z
Zhiping Li
H 指数:39论文数:374被引数:8,144